Price Alert

Grifols S.A. (GRFS)

NASDAQ: GRFS · Real-Time Price · USD

9.88

0.29 (3.02%)

At close: Sep 04, 2025, 10:12 AM

3.02% (1D)

Bid	9.88
Market Cap	8.36B
Revenue (ttm)	7.45B
Net Income (ttm)	297.45M
EPS (ttm)	0.51
PE Ratio (ttm)	19.38
Forward PE	8.64
Analyst	Hold

Ask	9.9
Volume	237,305
Avg. Volume (20D)	952,575
Open	9.92
Previous Close	9.59
Day's Range	9.84 - 9.96
52-Week Range	6.19 - 11.14
Beta	0.97

About GRFS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol GRFS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GRFS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+8.87%

Grifols shares are trading higher after the compan... Unlock content with Pro Subscription

9 months ago

Grifols shares are trading lower after the company ended discussions with Brookfield Capital Partners regarding a potential acquisition.

News

1 week ago · zacks.com

All You Need to Know About Grifols (GRFS) Rating Upgrade to Buy

Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 weeks ago · zacks.com

GRFS or NBIX: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang f...

2 weeks ago · zacks.com

Are Investors Undervaluing Grifols (GRFS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...